medigraphic.com
SPANISH

Boletín Clínico Hospital Infantil del Estado de Sonora

Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2015; 32 (1)

Pediculosis

Quiroz-Herbert MA, Reyes-Hernández KL, Sánchez-Chávez NP, Reyes-Gómez U, Hernández-Lira S, Reyes-Hernández D, Santamaría-Arza C, Reyes-Hernández U
Full text How to cite this article

Language: Spanish
References: 11
Page: 22-25
PDF size: 37.71 Kb.


Key words:

Children, ivermectin, Pediculuscapitis.

ABSTRACT

Pediculosis is an ectoparasite that emerged in recent years in children. TheWorld Health Organization considered it a reemerging disease in developing countries and where our country reporte dout breaks in different social strata in the last decade.
The causal agentis Pediculus humanus (body louse) This article is a general review of basic concepts and the way to attend thisdisease and its current management adressesed to pediatricians & primary care physicians.


REFERENCES

  1. 1.- Devera R.Epidemiología de la pediculosis capitis en América Latina 2012; 24(1): 25-36. 2.- Koch S. The classification of human lice.2008. Consultado en: http://bioweb.uwlax.edu/bio203/s2008/koch_sama/ index.html 3.- Zúñiga I, Caro J, Pediculosis: Una ectoparasitosis emergente en México, Rev Enf Infec Ped 2010; 24(3): 6-8. 4.- Feldmeier H. Pediculosis capitis: new insights into epidemiology, diagnosis and treatment, European Journal of Clinical Microbiology & Infectious Diseases 2012; 31(9): 2105-110.

  2. 5.- De Gentile L, Carsuzaa F. Escabiosis, pediculosis y picaduras de artrópodos, EMC - Dermatología 2013: 47(2): 1–12.

  3. 6.- Mahreen A, Arenas R, Villanueva J, Ruiz J. Ivermectina oral para el tratamiento de pediculosis capitis, PediatrInfectDis J 2010; 29: 991–3.

  4. 7.- Angelo QH, Fortuño VI, Reyes GU, Reyes HKL. Pediculosis en: Castañeda NJ. Prontuario de infectología Pedíatrica 4ª edición Mexico: editorial Trillas; 2014.p. 31.

  5. 8.- Madke B, Khopkar U. Pediculosis capitis: An update. Indian J Dermatol Venereol Leprol 2012; 78: 429-38.

  6. 9.- Arenas R. Pediculosis. Dermatologia. Atlas diagnóstico y tratamiento, segunda edicion. Mexico, Mc Graw-Hill Interamericana: 2004.p. 395-6.

  7. 10.- Gairi JM, Molina V, Moraga FA y col. Pediculosis de la cabeza. Protocolos diagnosticos y terapeuticos en dermatologia pediatrica: 2000.p.75-86.

  8. 11.- Escalante E, Valdivia L, Obregon L, Guillen R. Ivermectina oral en pediculosis capitis en poblacion infantil, Rev Fac Med, Universidad Ricardo Palma 2008; 8 (1): 14-8.

  9. 12.- Chosidow O, Giraudeau B, Cottrel J, et al. Oral Ivermectin versus Malathion Lotion for Difficult-to-treat Head Lice. NEJM 2010; 362: 896-905.

  10. 13.- Burgess FI, Brown MC, Lee NP. Treatment of head louse infestation with 4% dimeticonelotion: randomised controlled quivalence trial, BMJ 2005;330:1423–5.

  11. 14.- Hill C.Human Lice:biology and public health risk.2010. Consultado en: http://entensión.entm.purdue.edu/publichealth/ insects/louse.html




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Bol Clin Hosp Infant Edo Son. 2015;32